Welgene Biotech ,Ltd. Total Current Liabilities

Welgene Biotech ,Ltd. (6661.TWO) currently reports a total current liabilities of $160M as of June 2026. That compares with $130M in the prior-year period — up 20.3% year over year. Use the charts on this page to explore Welgene Biotech ,Ltd.'s total current liabilities history and peer comparisons.

Welgene Biotech ,Ltd.'s total current liabilities increased from $130M to $160M — a 20.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Welgene Biotech ,Ltd. reported $160M in total current liabilities as of June 2026. That compares with $130M in the prior-year period — up 20.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Welgene Biotech ,Ltd., and consider following 6661.TWO for alerts when major investors trade the stock.